Atlas FDA

MEDSTONE STS(TM) EXTRACORPOREAL SHOCK WAVE LITHOTR

FDA premarket approval P870015/S022 · decided 1996-08-19

Approval details

PMA number
P870015
Supplement
S022
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
MEDSTONE STS(TM) EXTRACORPOREAL SHOCK WAVE LITHOTR
Generic name
Lithotriptor, extracorporeal shock-wave, urological
Applicant
Medstone Intl., Inc.
Date received
1996-04-08
Decision date
1996-08-19
Days to decision
133 days
Decision code
APRL
Product code
LNS
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Aliso Viejo, CA
Statement
APPROVAL FOR HARDWARE AND SOFTWARE CHANGES TO YOUR MEDSTONE STS LITHOTRIPTER

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MEDSTONE, UROPRO 2000, TOMOGRAPHIC OPTION (K013620)Medstone Intl., Inc.2002-01-22
STS-T LITHOTRIPTER, MODEL STS-T (K010900)Medstone Intl., Inc.2001-04-05
STS(TM) FLUOROSCOPIC IMAGING MODULE (K905278)Medstone Intl., Inc.1991-02-04